ELISA assays demonstrated that plasma levels of IL-6, IL-18, IL-33, and COX-2 were significantly increased in AD patients carrying TOMM40 genetic variants, including rs772262361, rs157581, and rs11556505 (Figure 4 and Table 3). This evidence concerns the gene IL6 and Alzheimer disease.